Characteristics | Esophageal squamous cell carcinoma patients | |||
---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||
HR a (95% CI b) | P-value c | HR (95% CI) | P-value | |
SOX17 expression d |  |  |  |  |
 SOX17high | 1 |  | 1 |  |
 SOX17low | 2.529 (1.681–3.803) | < 0.001 | 2.767 (1.786–4.288) | < 0.001 |
NRF2 expression d |  |  |  |  |
 NRF2low | 1 |  | 1 |  |
 NRF2high | 1.660 (1.127–2.446) | 0.010 | 1.614 (1.076–2.421) | 0.021 |
SOX17/NRF2Â expressiond | Â | Â | Â | Â |
 SOX17high NRF2low | 1 |  | 1 |  |
 SOX17high NRF2high | 1.369 (0.661–2.883) | 0.397 | 1.403 (0.667–2.952) | 0.373 |
 SOX17low NRF2low | 2.125 (1.043–4.329) | 0.038 | 2.516 (1.207–5.245) | 0.014 |
 SOX17low NRF2high | 3.738 (1.965–7.110) | < 0.001 | 4.313 (2.218–8.384) | < 0.001 |
Age | Â | Â | Â | Â |
 < 55 year-old | 1 |  | 1 |  |
 ≥ 55 year-old | 1.274 (0.886–1.832) | 0.191 | 1.481 (1.002–2.189) | 0.049 |
Sex | Â | Â | Â | Â |
 Male | 1 |  | 1 |  |
 Female | 0.457 (0.169–1.239) | 0.124 | 0.397 (0.138–1.141) | 0.086 |
Smoker | Â | Â | Â | Â |
 No | 1 |  | 1 |  |
 Yes | 1.077 (0.645–1.797) | 0.777 | 0.915 (0.518–1.619) | 0.762 |
Stage | Â | Â | Â | Â |
 Stage I–III | 1 |  | 1 |  |
 Stage IV | 1.088 (0.769–1.540) | 0.633 | 1.150 (0.787–1.680) | 0.471 |
T status e |  |  |  |  |
 Stage I–III | 1 |  | 1 |  |
 Stage IV | 1.313 (0.857–2.011) | 0.211 | 1.224 (0.793–1.891) | 0.362 |
N status e |  |  |  |  |
 N0 | 1 |  | 1 |  |
 N1 | 1.072 (0.633–1.817) | 0.795 | 0.652 (0.363–1.170) | 0.152 |
M status e |  |  |  |  |
 M0 | 1 |  | 1 |  |
 M1 | 1.051 (0.741–1.489) | 0.782 | 1.117 (0.765–1.633) | 0.566 |